Patents by Inventor Jean-Marc Limacher

Jean-Marc Limacher has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTI-TUMORAL COMPOSITION
    Publication number: 20210138053
    Abstract: A pharmaceutical composition characterised in that it comprises at least one poxvirus, a naked nucleic acid sequence encoding at least one specific neoantigen of a cancerous cell and an anti-CTLA4 antibody.
    Type: Application
    Filed: January 19, 2021
    Publication date: May 13, 2021
    Inventor: Jean-Marc LIMACHER
  • ANTI-TUMORAL COMPOSITION
    Publication number: 20180296653
    Abstract: A pharmaceutical composition characterised in that it comprises at least one poxvirus, a naked nucleic acid sequence encoding at least one specific neoantigen of a cancerous cell and an anti-CTLA4 antibody.
    Type: Application
    Filed: October 7, 2016
    Publication date: October 18, 2018
    Inventor: Jean-Marc LIMACHER
  • USE OF PPD FOR THE ADJUVANTATION OF A NUCLEIC ACID VACCINE
    Publication number: 20090317422
    Abstract: The present invention provides a novel adjuvant for nucleic acid vaccines, and in particular the present invention provides nucleic acid vaccines that comprise, or are administered in association with PPD. The present invention also provides methods to improve the therapeutic efficacy of nucleic acid vaccines.
    Type: Application
    Filed: June 14, 2007
    Publication date: December 24, 2009
    Applicant: TRANSGENE S.A.
    Inventors: Jean-Yves Bonnefoy, Jean-Marc Limacher, Stéphane Paul